참고문헌
- Korea National Statistical Office. Annual report on the cause of death statistics, 2007. Daejeon: Korea National Statistical Office; 2008.
- Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007;12:20-37. https://doi.org/10.1634/theoncologist.12-1-20
- Asamura H, Goya T, Koshiishi Y, Sohara Y, Tsuchiya R, Miyaoka E. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg 2006;132:316-9. https://doi.org/10.1016/j.jtcvs.2006.03.048
- Visbal AL, Leighl NB, Feld R, Shepherd FA. Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest 2005;128:2933-43. https://doi.org/10.1378/chest.128.4.2933
- Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97. https://doi.org/10.1056/NEJMoa043623
- Scagliotti G. Multimodality approach to early-stage non-small cell lung cancer. Lung Cancer 2007;57 Suppl 2:S6-11.
- Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 2007;110:1532-41. https://doi.org/10.1002/cncr.22938
- Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7. https://doi.org/10.1378/chest.111.6.1710
- Greene FL. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002.
- Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-14. https://doi.org/10.1097/JTO.0b013e31812f3c1a
- Rami-Porta R, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 2009;15:4-9.
- Kobayashi N, Toyooka S, Soh J, Ichimura K, Yanai H, Suehisa H, et al. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less. J Thorac Oncol 2007;2:808-12. https://doi.org/10.1097/JTO.0b013e31814617c7
- Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N, Uchida O, et al. The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2007;13:73-7.
- Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, et al. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007;25:5506-18. https://doi.org/10.1200/JCO.2007.14.1226
- Kita H, Koshiishi Y, Masui K, Fujita A, Ootsuka K, Furuyashiki G, et al. Risk factors of recurrence in resected stage I non-small cell lung cancer. Kyobu Geka 2007;60:883-7.
- Fujisawa T, Yamaguchi Y, Saitoh Y, Hiroshima K, Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer 1995;76:2464-70. https://doi.org/10.1002/1097-0142(19951215)76:12<2464::AID-CNCR2820761210>3.0.CO;2-U
- Pechet TT, Carr SR, Collins JE, Cohn HE, Farber JL. Arterial invasion predicts early mortality in stage I non-small cell lung cancer. Ann Thorac Surg 2004;78:1748-53. https://doi.org/10.1016/j.athoracsur.2004.04.061